Adamax Research Guide
An evidence-mapped overview of the marketplace name Adamax covering what the live product page actually states, negative registry and literature lookups, a documented optimizer homonym, and why Semax papers cannot be re-labeled as Adamax evidence. Sequence is not established.
Not Semax
No indexed Adamax peptide papers
Research use only
Educational information only. Adamax is not an FDA-approved drug for human use. Laboratory research use only; not for human or animal use. Identity / evidence uncertain. No human dosing, reconstitution, or administration protocol appears on this page.
Quick Facts
Opened registry and literature lookups do not establish Adamax as a single indexed peptide. The live Simple Research Peptides page (Adamax 10 mg Research Compound Vial, fetched 16 August 2026) lists 10 mg lyophilized research material in the Brain & Mind Research category (SKU ADAMAX-10MG). That page claims ≥99% purity, a COA, Made in the USA, and third-party testing, and states: “For laboratory research only. Not for human or animal use, consumption, administration, diagnosis, treatment, or therapeutic application.” It published no amino-acid sequence, no CAS, no formula, no PubChem CID, and no UNII.
Registry payloads opened the same day:
- PubChem PUG REST name lookup
name=Adamax: HTTP 404. No Adamax compound record. - FDA/NCATS GSRS substances search
q=Adamax: total 0, content[]. - ClinicalTrials.gov v2 API
query.term=Adamax:{"studies":[]}. - PubMed
term=Adamax: 39 hits. The hit opened here, PMID 42236259 (Sawant & Ghongade, 2026, Diabetes Obes Metab), is an AdaMax optimizer paper, not a peptide. - Peptide-restricted PubMed queries (
Adamax+peptideORAdamax+SemaxOR"N-acetyl-Semax" adamantane; Title/AbstractAdamax AND (peptide OR Semax OR adamantane);N-acetyl-Semax/"N-acetyl Semax"/"acetyl-Semax"): 0 items.
Related but distinct — Semax, not Adamax. PubChem CID 9811102 is a Semax record (formula C37H51N9O10S, MW 813.9, InChIKey AFEHBIGDWIGTEH-AQRCPPRCSA-N). Synonyms on that record include Semax, 80714-61-0, ACTH (4-7), Pro-Gly-Pro-, I5FAL2585H, MEHFPGP, Met-Glu-His-Phe-Pro-Gly-Pro, H-Met-Glu-His-Phe-Pro-Gly-Pro-OH, UNII-I5FAL2585H. Dmitrieva et al. (2010) describe Semax as consisting of ACTH(4-7) plus C-terminal PGP and report a rat pMCAO neurotrophin-transcription study (PMID 19633950; PMCID PMC11498467). That is Semax evidence, not Adamax evidence.
What the name is — and is not
Adamax, as sold on the fetched SRP page, is a trade-style marketplace name for a 10 mg lyophilized research-compound vial. The live page does not disclose a sequence, CAS, formula, PubChem CID, or UNII. This review cannot assign a mechanism, receptor, or pharmacologic class to that name. Mechanism follows identity. Identity is not documented in the opened registries or in an indexed Adamax peptide paper.
Semax is a related but distinct heptapeptide (Met-Glu-His-Phe-Pro-Gly-Pro) with its own PubChem record (CID 9811102) and one opened primary paper (PMID 19633950). Semax is not Adamax. Marketplace copy that treats Adamax as “a stronger Semax,” “N-acetyl Semax,” or “adamantane-Semax” is not a substitute for a disclosed structure plus a paper that used that structure.
The only PubMed record opened under the bare term Adamax in this review is an optimizer homonym (PMID 42236259), not a peptide study.
Cannot be assigned until identity is documented
There is no invented receptor diagram and no fake chart on this page. Observed means a payload actually opened. Related / distinct means Semax, not Adamax. Marketing means vendor copy, not a paper. Not shown means this review did not open such a paper.
No assignable pathway
No opened paper administered a peptide named Adamax. No receptor, transporter, enzyme, or signaling cascade can be assigned to an undisclosed structure.
AdaMax is not a peptide here
Sawant & Ghongade (2026) use “AdaMax” as a machine-learning optimizer in a glucose-dynamics / diabetes-management network paper (PMID 42236259). Name collision, not peptide pharmacology.
Neurotrophin transcription is Semax data
Dmitrieva et al. (2010): Semax (ACTH(4-7) + C-terminal PGP) and Pro-Gly-Pro activated transcription of neurotrophins and their receptor genes after cerebral ischemia in a rat pMCAO model (PMID 19633950). The opened abstract’s stroke-therapy sentence is about Semax. It is not an Adamax clinical claim.
BBB / BDNF / “stronger Semax”
Vendor claims that Adamax crosses the blood–brain barrier, raises BDNF, or is a more stable Semax analogue are unsourced relative to the opened record. They require a disclosed structure and a paper that used that structure.
Gaps that block a mechanism
No Adamax peptide sequence, CAS, formula, or registry ID. No Adamax peptide binding table, PK curve, or in-vivo study. No human cognition outcomes. No BBB, BDNF, or adamantane-PK results with Adamax. No equivalence to Semax or N-acetyl Semax amidate.
What the vial listing actually says
10 mg lyophilized research material; Brain & Mind Research; laboratory/research only. No sequence on the fetched page. Purity and COA claims on a product page are not a mechanism and are not a literature identity.
Where the record actually sits
Label every cluster. Adamax peptide would mean a paper that named Adamax as the test article. Not found means this review did not open such a paper. Related but distinct means Semax.
No compound record
PubChem name=Adamax: HTTP 404. GSRS q=Adamax: 0 substances. ClinicalTrials.gov query.term=Adamax: 0 studies. SRP page: 10 mg lyophilized research material; no sequence, CAS, formula, PubChem, or UNII.
Three incompatible write-ups
Some pages: N-adamantyl-Semax (Ad-MEHFPGP). Some: 9-residue Ac-MEHFPGPAG-NH2 with C-terminal adamantane. Some: N-Acetyl Semax Amidate (Ac-MEHFPGP-NH2), no adamantane. A name alone is not a structure. This page does not pick a winner.
AdaMax optimizer
PubMed term=Adamax returned 39 hits. The opened paper is Sawant & Ghongade 2026, a diabetes / glucose-dynamics network study using the AdaMax optimizer (PMID 42236259). Not a peptide.
Registry + one opened paper
PubChem CID 9811102: Semax; C37H51N9O10S; MW 813.9; MEHFPGP; CAS 80714-61-0; UNII I5FAL2585H. Dmitrieva 2010: Semax + PGP, rat pMCAO neurotrophin transcription (PMID 19633950). Do not re-label as Adamax.
Filtered PubMed = 0
Adamax+peptide OR Adamax+Semax OR “N-acetyl-Semax” adamantane: 0 items. Title/Abstract Adamax AND (peptide OR Semax OR adamantane): 0 items. N-acetyl-Semax name variants: 0 items.
Unsourced for this name
No opened Adamax peptide paper measured human cognition, blood–brain-barrier penetration, BDNF, or adamantane PK. No opened combination-product paper. Semax neurotrophin data remain Semax data.
What was studied, in what system
Read the “compound actually studied” column first. Published study designs are historical facts from those papers. They are not a protocol.
| Domain | Compound actually studied | System | Status | Source |
|---|---|---|---|---|
| Marketplace listing | Name “Adamax”; 10 mg lyophilized vial | SRP product page, fetched 16 Aug 2026 | Trade name; no sequence | SRP product URL |
| PubChem name lookup | Query name=Adamax | PUG REST property | HTTP 404; no record | PubChem PUG REST |
| FDA/NCATS substance | Query q=Adamax | GSRS substances search | 0 substances | FDA/NCATS GSRS |
| Clinical trials | Query term=Adamax | ClinicalTrials.gov v2 API | 0 studies | ClinicalTrials.gov |
| PubMed name search | Term=Adamax (39 hits) | Bibliographic index | Opened hit is not a peptide | PMID 42236259 |
| Optimizer homonym | AdaMax optimizer | Diabetes / glucose-dynamics network paper | NOT A PEPTIDE | PMID 42236259 |
| Peptide-filtered PubMed | Adamax + peptide / Semax / adamantane | Title/Abstract and combined queries | 0 items | PubMed esearch |
| N-acetyl-Semax PubMed | N-acetyl-Semax name variants | Bibliographic index | 0 items | PubMed esearch |
| Semax registry | Semax (MEHFPGP) | PubChem CID 9811102 | Related but distinct | CID 9811102 |
| Semax neurotrophin transcription | Semax and Pro-Gly-Pro | Rat pMCAO | RELATED BUT DISTINCT | PMID 19633950 |
| Adamax peptide pharmacology | — | — | Not found | This review |
How the opened record sits
Not an Adamax study
Dmitrieva et al.: Semax and Pro-Gly-Pro activate neurotrophin and receptor-gene transcription after cerebral ischemia in the rat; opened abstract frames Semax as ACTH(4-7) + PGP (PMID 19633950). Semax evidence only.
Three incompatible “Adamax” structures
Vendor / encyclopedia pages disagree: N-adamantyl-Semax (Ad-MEHFPGP); 9-residue Ac-MEHFPGPAG-NH2 plus C-terminal adamantane; N-Acetyl Semax Amidate without adamantane. Flagged as marketing. Not used as structure.
Opened PubMed Adamax hit is not a peptide
Sawant & Ghongade, Diabetes Obes Metab: glucose-dynamics analysis network paper using the AdaMax optimizer (PMID 42236259).
Negative peptide identity lookups
SRP product page fetched (10 mg lyophilized research material; no sequence). PubChem name=Adamax 404. GSRS 0. ClinicalTrials.gov 0. Peptide-restricted PubMed 0. Semax CID 9811102 opened only as a related-but-distinct record.
What is not established
These are gaps in the opened record. Treating any of them as settled is incorrect.
Sequence is not established
The SRP page does not give a sequence. PubChem, GSRS, and UNII lookups for Adamax returned nothing. Vendor write-ups that assign Ad-MEHFPGP, Ac-MEHFPGPAG-NH2-plus-adamantane, or Ac-MEHFPGP-NH2 are incompatible with each other and are not evidence.
Not Semax
Semax has a PubChem record (CID 9811102) and an opened primary paper (PMID 19633950). Adamax does not inherit Semax identity, Semax stroke-therapy framing, or Semax neurotrophin results.
No indexed Adamax peptide papers
Peptide-, Semax-, and adamantane-restricted PubMed queries returned 0 items. The opened Adamax-named paper is an optimizer homonym (PMID 42236259).
Human cognition is not established
No opened paper reports human memory, focus, attention, mood, or “nootropic” outcomes with a peptide named Adamax.
BBB, BDNF, and adamantane-PK claims are not established
No opened Adamax peptide paper measured blood–brain-barrier penetration, BDNF/NGF, or adamantane-related pharmacokinetics. The opened neurotrophin paper used Semax.
Semax equivalence is not established
Even if a future COA disclosed a Semax-related conjugate, that would still not make Semax papers into Adamax papers. The three circulating vendor structures are not the same molecule.
No approved therapeutic use
No GSRS substance, no ClinicalTrials.gov study, no FDA-approved finished drug in the sources opened here. The SRP page is research-use only.
No human dosing on this page
There is no human dosing, reconstitution, or administration protocol here. Research-use only; not an FDA-approved drug for human use.
| Popular claim | Status after this review |
|---|---|
| “Adamax is N-adamantyl-Semax (Ad-MEHFPGP)” | Marketing, not evidence. One of three incompatible vendor structures. SRP page silent. |
| “Adamax is Ac-MEHFPGPAG-NH2 with C-terminal adamantane” | Marketing, not evidence. Incompatible with the other two write-ups. |
| “Adamax is N-Acetyl Semax Amidate (no adamantane)” | Marketing, not evidence. Omits adamantane; cannot be the same molecule as the adamantane write-ups. |
| “Same thing as Semax” | False as identity. Semax is CID 9811102 / MEHFPGP. Adamax has no opened record. |
| “Published Adamax peptide papers / BDNF / BBB” | Not found in opened Adamax peptide searches. Semax neurotrophin data are Semax data. |
| “Human cognition / nootropic peptide” | Not found in a paper opened here. |
| “Indexed clinical trials” | ClinicalTrials.gov v2: 0 studies. |
| Marketplace vial = a registered peptide | Not established. Sequence, MS identity, and distinction from Semax-family names must be documented analytically. |
Primary records in this map
Every PMID below is from the verified set used to build this page. Allowed PMIDs on this page: 42236259 and 19633950 only.
Sawant & Ghongade, 2026 — Diabetes Obes Metab
Opened under PubMed term=Adamax. Title begins “Diabetes Management Through Glucose Dynamics Analysis Network…”. The Adamax string in this hit is the AdaMax optimizer, not a peptide. PMID 42236259. Do not cite as Adamax peptide evidence.
Dmitrieva VG, Povarova OV, Skvortsova VI, Limborska SA, Myasoedov NF, Dergunova LV, 2010 — Cell Mol Neurobiol
Semax and Pro-Gly-Pro activate the transcription of neurotrophins and their receptor genes after cerebral ischemia. Rat pMCAO study. Opened abstract: “Consisting of a fragment of ACTH(4-7) and C-terminal PGP tripeptide, the polypeptide Semax is successfully used for acute stroke therapy.” PMID 19633950. doi: 10.1007/s10571-009-9432-0. PMCID PMC11498467. This is Semax evidence, not Adamax.
Research-only caution
Adamax, as listed on the fetched SRP page, is a research-compound marketplace name. It is not an FDA-approved drug for human use. This page is educational. It does not provide dosing, reconstitution, administration, or any human-use instructions.
SRP material is for laboratory research only. It is not for human or animal use, consumption, administration, diagnosis, treatment, or therapeutic application.
Laboratory identity is the first practical issue — and it is unresolved. Before treating a vial as a literature compound:
- Require sequence disclosure (full residue string, termini, and any N- or C-terminal modification). A trade name is not enough.
- Require a COA with mass spectrometry (and complementary identity methods) that matches the disclosed sequence. Purity percentage alone does not identify the molecule.
- Distinguish the lot from Semax (MEHFPGP; CID 9811102; CAS 80714-61-0; UNII I5FAL2585H), from N-acetyl Semax amidate (Ac-MEHFPGP-NH2 as used in some vendor write-ups), and from adamantane conjugates (Ad-MEHFPGP or a 9-residue adamantane write-up). Those names are not interchangeable.
- Do not import Semax methods, Semax neurotrophin readouts, or Semax stroke-therapy framing onto an unidentified vial.
Common questions
What is Adamax?
A marketplace / trade-style name. The fetched SRP page lists a 10 mg lyophilized research-compound vial (Brain & Mind Research; SKU ADAMAX-10MG) and does not give a sequence, CAS, formula, PubChem CID, or UNII. Opened registries returned no Adamax compound. Identity is uncertain.
Is it the same as Semax?
No. Semax is a documented heptapeptide (Met-Glu-His-Phe-Pro-Gly-Pro; PubChem CID 9811102). Adamax has no opened compound record. Semax papers are not Adamax papers.
What sequence is reported?
None established in opened sources. The SRP page is silent. Public vendor write-ups disagree (N-adamantyl-Semax vs a 9-residue adamantane conjugate vs N-Acetyl Semax Amidate without adamantane). Those cannot all be the same molecule. This page does not invent a sequence.
Are there published Adamax peptide papers?
Not in the opened, peptide-restricted PubMed searches (0 items). A bare “Adamax” search hit opened here is an AdaMax optimizer paper (PMID 42236259), not a peptide.
Did this review find clinical trials?
No. ClinicalTrials.gov v2 API query.term=Adamax returned no studies. GSRS search returned 0 substances.
Does Adamax raise BDNF, cross the BBB, or improve cognition?
Not established in an opened Adamax peptide paper. The opened neurotrophin-transcription paper used Semax (PMID 19633950).
Is Adamax FDA-approved?
No. Educational information only. Not an FDA-approved drug for human use. Research compound listing only.
Does this page include human dosing?
No. There is no human dosing, reconstitution, or administration protocol on this page.
Citations used on this page
Full citations for the verified set. Each line is a paper or registry record actually opened for this page. One-line findings are from those opened abstracts or API payloads. Allowed PMIDs: 42236259 and 19633950 only.
- Sawant & Ghongade. Diabetes Management Through Glucose Dynamics Analysis Network… Diabetes Obes Metab. 2026. PMID 42236259. Opened as the PubMed
term=Adamaxhit. AdaMax optimizer — not a peptide. - Dmitrieva VG, Povarova OV, Skvortsova VI, Limborska SA, Myasoedov NF, Dergunova LV. Semax and Pro-Gly-Pro activate the transcription of neurotrophins and their receptor genes after cerebral ischemia. Cell Mol Neurobiol. 2010;30(1):71-9. doi: 10.1007/s10571-009-9432-0. PMID 19633950. PMCID PMC11498467. Rat pMCAO neurotrophin transcription. Semax, not Adamax.
- PubChem PUG REST name=Adamax property lookup: HTTP 404. No Adamax compound record.
- PubChem CID 9811102 (Semax, related but distinct): C37H51N9O10S; MW 813.9; InChIKey AFEHBIGDWIGTEH-AQRCPPRCSA-N; synonyms include Semax, 80714-61-0, I5FAL2585H, MEHFPGP, Met-Glu-His-Phe-Pro-Gly-Pro, UNII-I5FAL2585H. https://pubchem.ncbi.nlm.nih.gov/compound/9811102
- FDA/NCATS GSRS substances search q=Adamax: total 0, content [].
- ClinicalTrials.gov v2 API query.term=Adamax: {“studies”:[]}.
- PubMed esearch term=Adamax: 39 hits; opened hit is PMID 42236259 (optimizer). Peptide-restricted and N-acetyl-Semax queries: 0 items.
- Simple Research Peptides. Adamax 10 mg Research Compound Vial product page. http://simpleresearchpeptides.com/product/adamax-10-mg-vial/ Fetched 16 August 2026. Listed 10 mg lyophilized research material. Research use only.
- Simple Research Peptides. Semax 10 mg vial (related listing; distinct peptide). http://simpleresearchpeptides.com/product/semax-10-mg-vial/
- Simple Research Peptides. Compound Research Guides directory. http://simpleresearchpeptides.com/research-compound-directory/compound-research-guides/
Sources searched but not used as evidence: public vendor / encyclopedia pages that call Adamax N-adamantyl-Semax (Ad-MEHFPGP), a 9-residue Ac-MEHFPGPAG-NH2 with C-terminal adamantane, or N-Acetyl Semax Amidate (Ac-MEHFPGP-NH2) — flagged as marketing, not evidence, and not cited as structure; any Semax paper other than the opened PMID 19633950; price and sales copy from the product page, except as a fetch note that the live page listed 10 mg lyophilized research material.
Educational information only. Adamax is not an FDA-approved drug for human use. Identity / evidence uncertain. Laboratory research use only; not for human or animal use. Last source review: 16 August 2026 (America/Indianapolis). Product URL, PubChem, GSRS, ClinicalTrials.gov, and PubMed queries were opened the same day. Allowed PMIDs: 42236259, 19633950.